BIIB
Biogen Inc.Healthcare$177.34
▲ Bullish
Mkt Cap: $26.03B|Float: 146.3M|SI: 3.0%|DTC: 4.8
Data as of market close Apr 2, 2026
IV Rank
37
IV Pctl
22%
HV 20d
37.9%
52W Range
$110-$202
ATR(14)
$6.21
Exp. Move
±2.1%
P/C Ratio
1.17
Earnings
Apr 30
GEX Positive
DEX Long
Net Call Premium
IV Moderate
Max Pain Above
Exp. Move Moderate
BIIB Key Options Data
- IV Rank
- 37.2%
- Total GEX
- $0.00B
- Total DEX
- $1.2M
- Max Pain
- $182.50
- Expected Move
- ±2.1%
- Put/Call OI
- 1.17
- Net Premium
- $0.1M
- Spot Price
- $177.34
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$3.65 | ±2.1% | $173.69 | $180.99 |
| 2026-04-17 | 15 | ±$4.03 | ±2.3% | $173.31 | $181.36 |
| 2026-04-24 | 22 | ±$5.15 | ±2.9% | $172.19 | $182.49 |
| 2026-05-01 | 29 | ±$16.50 | ±9.3% | $160.84 | $193.84 |
| 2026-05-08 | 36 | ±$3.60 | ±2.0% | $173.74 | $180.94 |
| 2026-05-15 | 43 | ±$8.10 | ±4.6% | $169.24 | $185.44 |
Explore BIIB options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.